Steris (STE) EBIT (2018 - 2026)

Steris has reported EBIT for 9 years, with the latest figure at $285.8 million in Q2 2026.

• On a quarterly basis, EBIT rose 16.18% year-over-year to $285.8 million in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 23.14% increase from a year earlier, with the FY2026 full-year figure at $1.1 billion, up 27.14% from the prior year.
• EBIT was $285.8 million for Q2 2026 at Steris, down from $316.8 million in the prior quarter.
• The five-year high for EBIT was $748.3 million in Q1 2023, with the low at -$306.4 million in Q3 2022.
• Average EBIT over 5 years is $223.6 million, with a median of $220.0 million recorded in 2024.
• The largest YoY upside for EBIT was 1005.8% in 2022 against a maximum downside of 363.01% in 2022.
• Over 5 years, EBIT stood at $190.8 million in 2022, then gained by 18.69% to $226.5 million in 2023, then climbed by 8.31% to $245.3 million in 2024, then gained by 11.37% to $273.2 million in 2025, then advanced by 4.61% to $285.8 million in 2026.
• The last three EBIT figures came in at $285.8 million (Q2 2026), $316.8 million (Q1 2026), and $273.2 million (Q4 2025), per Business Quant data.